Institut Curie Names Intel Lead Partner to Implement HPC and AI for Oncological Genome Sequencing and Interpretation

May 23, 2018

PARIS, May 23, 2018 — Institut Curie and Intel initiate a pioneering collaboration to develop, use and implement innovative bioinformatics tools, pipelines and techniques to improve the use of molecular profiling across both research and clinical oncology settings.

On Wednesday, Intel CEO Brian Krzanich met with French Président Emmanuel Macron during the Tech For Good Summit in Paris. Deeply conscious of what technology and artificial intelligence (AI) can do for the economy and society and with an unprecedented assembly of tech leaders from across the globe, the summit aims to establish the world’s foremost venue for frank and open conversations about technology’s central role in the modern world. The summit was the opportunity for Krzanich to discuss the new collaboration with the French Institut Curie around use of artificial intelligence to provide personalized cancer treatment.

Precision medicine for cancer requires the delivery of individually adapted medical care based on the genetic characteristics of each patient. The last decade witnessed the development of high-throughput technologies such as next-generation sequencing, which paved their way in the field of oncology. While the cost of these technologies decreases, we are facing an exponential increase in the amount of data produced. In order to open access to precision medicine-based therapies to more patients, healthcare providers have to rationalize both their data production and utilization. This requires the implementation of cutting-edge technologies: high-performance computing and artificial intelligence (AI).

Before making a therapeutic decision based on the genome interpretation of a cancer, the physician can be presented with an overwhelming number of gene variants. In order to identify key actionable variants that can be targeted by treatments, the physician needs tools to sift through this large volume of variants. While the use of AI in genome interpretation is still nascent, it is growing rapidly, acting as a filter to dramatically reduce the number of variants and providing invaluable help to physicians. The mastering of high-performance computing methods on modern hardware infrastructures is becoming a key factor in the cancer genome interpretation process while being efficient, cost-effective and adjustable over time.

The pioneer collaboration initiated between the Curie Institute Bioinformatics platform and Intel aims at answering those challenges by defining a leading model in France and Europe. This collaboration will grant Institut Curie access to Intel experts for defining high-performance computing and artificial intelligence infrastructure and ensuring its optimization in order to implement the Intel Genomics ecosystem partner solutions and best practices, for example the Broad Institute for Cancer Genomics pipeline optimization. Also anticipated is the development of additional tailored tools needed to integrate and analyze heterogeneous biomedical data. The collaboration will implement Intel® Select Solutions for Genomics Analytics based on Intel® Xeon® Scalable processors and Intel® Omni-Path Architecture.

“Artificial intelligence holds great promise for medical progress including genomics,” said Brian Krzanich, Intel CEO. “The Intel-Institut Curie collaboration is one more example of Intel’s commitment to the development of bold artificial intelligence research for the good of humanity.”

“Collaborating with Intel, Institut Curie will develop, use and implement Innovative Bioinformatics technologies to improve time to diagnosis, diagnostic accuracy, targeted treatment recommendations, and provide a better understanding of application needs to develop features that are needed for the healthcare sector,” said Emmanuel Barillot, head of the Institut Curie Bioinformatics platform and director of the Bioinformatics, Biostatistics, Epidemiology and Computational Systems Research Unit (U900, Institut Curie /INSERM/ Mines Paris Tech).

Amaury Martin, lead of Institut Curie Technology Transfer and Industrial Partnerships Office and director of the Institut Carnot Curie Cancer said, “This agreement with Intel, the world leader in the sector, marks a major step in the collaboration between Institut Curie and companies. It is a mark of recognition for the Institut Curie in the field of genetics, bioinformatics and precision medicine, and its unique model ranging from basic research to care. This agreement is undeniably an additional asset for the success of the Paris region platform SeqOIA co-founded between the APHP, Gustave-Roussy and Institut Curie within the framework of the France Medicine Genomic 2025 Plan.”

About Institut Curie

Institut Curie, a leading player in the fight against cancer, combines a leading French research center in oncology and a state-of-the-art hospital group that treat all types of cancer, including the rarest. Founded in 1909 by Marie Curie, the Institut Curie brings together more than 3,300 researchers, physicians and healthcare professionals around its three missions: care, research and teaching. As a private foundation recognized for public utility, Institut Curie is authorized to receive donations and bequests and can, thanks to the support of its donors, accelerate discoveries and thus improve the treatment and the quality of life of the patients. For information: www.curie.fr.


Source: Intel

Subscribe to HPCwire's Weekly Update!

Be the most informed person in the room! Stay ahead of the tech trends with industy updates delivered to you every week!

InfiniBand Still Tops in Supercomputing

July 19, 2018

In the competitive global HPC landscape, system and processor vendors, nations and end user sites certainly get a lot of attention--deservedly so--but more than ever, the network plays a crucial role. While fast, perform Read more…

By Tiffany Trader

HPC for Life: Genomics, Brain Research, and Beyond

July 19, 2018

During the past few decades, the life sciences have witnessed one landmark discovery after another with the aid of HPC, paving the way toward a new era of personalized treatments based on an individual’s genetic makeup Read more…

By Warren Froelich

WCRP’s New Strategic Plan for Climate Research Highlights the Importance of HPC

July 19, 2018

As climate modeling increasingly leverages exascale computing and researchers warn of an impending computing gap in climate research, the World Climate Research Programme (WCRP) is developing its new Strategic Plan – and high-performance computing is slated to play a critical role. Read more…

By Oliver Peckham

HPE Extreme Performance Solutions

Introducing the First Integrated System Management Software for HPC Clusters from HPE

How do you manage your complex, growing cluster environments? Answer that big challenge with the new HPC cluster management solution: HPE Performance Cluster Manager. Read more…

IBM Accelerated Insights

Are Your Software Licenses Impeding Your Productivity?

In my previous article, Improving chip yield rates with cognitive manufacturing, I highlighted the costs associated with semiconductor manufacturing, and how cognitive methods can yield benefits in both design and manufacture.  Read more…

U.S. Exascale Computing Project Releases Software Technology Progress Report

July 19, 2018

As is often noted the race to exascale computing isn’t just about hardware. This week the U.S. Exascale Computing Project (ECP) released its latest Software Technology (ST) Capability Assessment Report detailing progress so far. Read more…

By John Russell

InfiniBand Still Tops in Supercomputing

July 19, 2018

In the competitive global HPC landscape, system and processor vendors, nations and end user sites certainly get a lot of attention--deservedly so--but more than Read more…

By Tiffany Trader

HPC for Life: Genomics, Brain Research, and Beyond

July 19, 2018

During the past few decades, the life sciences have witnessed one landmark discovery after another with the aid of HPC, paving the way toward a new era of perso Read more…

By Warren Froelich

D-Wave Breaks New Ground in Quantum Simulation

July 16, 2018

Last Friday D-Wave scientists and colleagues published work in Science which they say represents the first fulfillment of Richard Feynman’s 1982 notion that Read more…

By John Russell

AI Thought Leaders on Capitol Hill

July 14, 2018

On Thursday, July 12, the House Committee on Science, Space, and Technology heard from four academic and industry leaders – representatives from Berkeley Lab, Argonne Lab, GE Global Research and Carnegie Mellon University – on the opportunities springing from the intersection of machine learning and advanced-scale computing. Read more…

By Tiffany Trader

HPC Serves as a ‘Rosetta Stone’ for the Information Age

July 12, 2018

In an age defined and transformed by its data, several large-scale scientific instruments around the globe might be viewed as a ‘mother lode’ of precious data. With names seemingly created for a ‘techno-speak’ glossary, these interferometers, cyclotrons, sequencers, solenoids, satellite altimeters, and cryo-electron microscopes are churning out data in previously unthinkable and seemingly incomprehensible quantities -- billions, trillions and quadrillions of bits and bytes of electro-magnetic code. Read more…

By Warren Froelich

Tsinghua Powers Through ISC18 Field

July 10, 2018

Tsinghua University topped all other competitors at the ISC18 Student Cluster Competition with an overall score of 88.43 out of 100. This gives Tsinghua their s Read more…

By Dan Olds

HPE, EPFL Launch Blue Brain 5 Supercomputer

July 10, 2018

HPE and the Ecole Polytechnique Federale de Lausannne (EPFL) Blue Brain Project yesterday introduced Blue Brain 5, a new supercomputer built by HPE, which displ Read more…

By John Russell

Pumping New Life into HPC Clusters, the Case for Liquid Cooling

July 10, 2018

High Performance Computing (HPC) faces some daunting challenges in the coming years as traditional, industry-standard systems push the boundaries of data center Read more…

By Scott Tease

Leading Solution Providers

SC17 Booth Video Tours Playlist

Altair @ SC17

Altair

AMD @ SC17

AMD

ASRock Rack @ SC17

ASRock Rack

CEJN @ SC17

CEJN

DDN Storage @ SC17

DDN Storage

Huawei @ SC17

Huawei

IBM @ SC17

IBM

IBM Power Systems @ SC17

IBM Power Systems

Intel @ SC17

Intel

Lenovo @ SC17

Lenovo

Mellanox Technologies @ SC17

Mellanox Technologies

Microsoft @ SC17

Microsoft

Penguin Computing @ SC17

Penguin Computing

Pure Storage @ SC17

Pure Storage

Supericro @ SC17

Supericro

Tyan @ SC17

Tyan

Univa @ SC17

Univa

  • arrow
  • Click Here for More Headlines
  • arrow
Do NOT follow this link or you will be banned from the site!
Share This